Latest Insider Transactions at Verrica Pharmaceuticals Inc. (VRCA)
This section provides a real-time view of insider transactions for Verrica Pharmaceuticals Inc. (VRCA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Verrica Pharmaceuticals Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Verrica Pharmaceuticals Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2024
|
Paul B Manning |
SELL
Bona fide gift
|
Direct |
450,000
-1.71%
|
-
|
|
Nov 26
2024
|
John A Stalfort Iii |
BUY
Bona fide gift
|
Direct |
50,000
+2.6%
|
-
|
|
Nov 26
2024
|
Jayson Rieger CEO and President |
BUY
Bona fide gift
|
Direct |
50,000
+5.36%
|
-
|
|
Nov 22
2024
|
Paul B Manning |
BUY
Open market or private purchase
|
Indirect |
4,494,382
+42.92%
|
-
|
|
Nov 22
2024
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
18,426,966
+41.22%
|
-
|
|
Nov 22
2024
|
John A Stalfort Iii |
BUY
Open market or private purchase
|
Direct |
1,123,595
+38.12%
|
-
|
|
Nov 22
2024
|
Jayson Rieger CEO and President |
BUY
Open market or private purchase
|
Direct |
280,898
+25.22%
|
-
|
|
Nov 06
2024
|
John J. Kirby Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
54,267
+50.0%
|
-
|
|
Sep 19
2024
|
Paul B Manning |
BUY
Bona fide gift
|
Indirect |
2,675,610
+50.0%
|
-
|
|
Sep 19
2024
|
Paul B Manning |
SELL
Bona fide gift
|
Indirect |
2,675,611
-100.0%
|
-
|
|
Aug 27
2024
|
Ted White PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
9,021
-4.01%
|
$18,042
$2.46 P/Share
|
|
Aug 27
2024
|
Terry Kohler CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,899
-15.02%
|
$15,798
$2.46 P/Share
|
|
Aug 27
2024
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,993
-10.95%
|
$17,986
$2.46 P/Share
|
|
Aug 27
2024
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,601
-3.68%
|
$7,202
$2.46 P/Share
|
|
Aug 27
2024
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,530
-8.27%
|
$19,060
$2.46 P/Share
|
|
Aug 26
2024
|
Ted White PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
24,979
-9.99%
|
$49,958
$2.66 P/Share
|
|
Aug 26
2024
|
Terry Kohler CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,820
-29.32%
|
$43,640
$2.66 P/Share
|
|
Aug 26
2024
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
24,709
-23.13%
|
$49,418
$2.66 P/Share
|
|
Aug 26
2024
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,888
-9.18%
|
$19,776
$2.66 P/Share
|
|
Aug 26
2024
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
26,183
-18.51%
|
$52,366
$2.66 P/Share
|
|
Jul 23
2024
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
91
-0.06%
|
$546
$6.98 P/Share
|
|
Jul 23
2024
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
86
-0.08%
|
$516
$6.98 P/Share
|
|
Jul 23
2024
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
115
-0.11%
|
$690
$6.98 P/Share
|
|
Jul 23
2024
|
Ted White PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
154
-0.06%
|
$924
$6.98 P/Share
|
|
Jul 22
2024
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,649
-13.26%
|
$151,543
$7.06 P/Share
|
|
Jul 22
2024
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,421
-14.59%
|
$128,947
$7.06 P/Share
|
|
Jul 22
2024
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,461
-19.23%
|
$178,227
$7.06 P/Share
|
|
Jul 22
2024
|
Ted White PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
32,469
-11.49%
|
$227,283
$7.06 P/Share
|
|
Mar 15
2024
|
Ted White PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
112,500
+28.47%
|
-
|
|
Mar 15
2024
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+23.2%
|
-
|
|
Mar 15
2024
|
Terry Kohler CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+34.96%
|
-
|
|
Mar 15
2024
|
Gary Goldenberg Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+24.06%
|
-
|
|
Mar 15
2024
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+19.68%
|
-
|
|
Dec 29
2023
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
115,774
+1.6%
|
$810,418
$7.24 P/Share
|
|
Dec 28
2023
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
126,116
+1.77%
|
$882,812
$7.08 P/Share
|
|
Dec 27
2023
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
79,726
+1.15%
|
$558,082
$7.2 P/Share
|
|
Dec 26
2023
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
54,652
+0.8%
|
$327,912
$6.49 P/Share
|
|
Dec 22
2023
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+3.59%
|
$1,500,000
$6.67 P/Share
|
|
Dec 21
2023
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+3.0%
|
$1,200,000
$6.17 P/Share
|
|
Dec 19
2023
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
277,008
+4.23%
|
$1,385,040
$5.36 P/Share
|
|
Dec 18
2023
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
456,923
+7.08%
|
$2,284,615
$5.41 P/Share
|
|
Dec 15
2023
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500,000
+8.28%
|
$2,500,000
$5.97 P/Share
|
|
Nov 15
2023
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,266
-10.87%
|
$22,532
$2.97 P/Share
|
|
Nov 15
2023
|
Terry Kohler CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,632
-21.87%
|
$19,264
$2.97 P/Share
|
|
Nov 15
2023
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,036
-3.4%
|
$6,072
$2.97 P/Share
|
|
Nov 15
2023
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,558
-8.58%
|
$23,116
$2.97 P/Share
|
|
Nov 15
2023
|
Ted White PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
11,558
-6.36%
|
$23,116
$2.97 P/Share
|
|
Nov 14
2023
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,580
-17.23%
|
$43,160
$2.93 P/Share
|
|
Nov 14
2023
|
Terry Kohler CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
18,452
-29.52%
|
$36,904
$2.93 P/Share
|
|
Nov 14
2023
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,817
-6.12%
|
$11,634
$2.93 P/Share
|